{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:32:32Z","timestamp":1789792352985,"version":"4.0.1"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>In 1949, Cade described \u201csedative effects\u201d after injecting guinea pigs intraperitoneally with lithium (LTM) carbonate. Based on his experiments, he began treating psychiatric patients with LTM. This literature review aims to evaluate the clinical epidemiological profile, pathological mechanisms, and management of LTM-associated movement disorder (MD). Relevant reports in six databases (Excerpta Medica, Google Scholar, Latin American and Caribbean Health Sciences Literature, Medline, Scientific Electronic Library Online, and ScienceDirect) were identified and assessed by two reviewers without language restriction from 1949 to 2021. A total of 250 reports containing 1100 individuals who developed MD associated with LTM were identified. The MDs encountered 148 parkinsonism (PKN), 114 dyskinesia (DKN), 97 myoclonus, 22 dystonia (DTN), 20 Creutzfeldt\u2013Jakob-like syndrome, 11 akathisia, 10 restless legs syndrome (RLS) symptoms, 6 tics, 5 cerebellar syndromes, and 3 stuttering. In the subgroup of cases not clearly defined, there were 320 individuals with extrapyramidal symptoms, 135 with DTN, 37 with DKN, 24 with PKN, and 7 with RLS. Other 141 individuals were only described as presenting an abnormal involuntary movement without further explanation. The mean age was 53.06 years (standard deviation [SD]: 15.64) and the predominant sex was female, i.e., 56.20% (154\/274). The mean LTM dose was 963.03 mg\/day (SD: 392.03). The mean serum LTM level was 1.53 mEq\/L (SD: 1.08). The median onset time was 3 months (1 day to 40 years). The mean recovery time was 0.94 months (SD: 0.87). 45.94% had a full recovery. LTM-induced MD was extensively reported in the literature. Only general terms were used in the majority of the reports. LTM polytherapy probably affected the identification of the MD cause.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/bc.bc_77_21","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T09:39:55Z","timestamp":1656581995000},"page":"76-86","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Lithium-associated movement disorder"],"prefix":"10.4103","volume":"8","author":[{"given":"Jamir Pitton","family":"Rissardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Let\u00edcia Fornari","family":"Caprara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cdcaro","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Rauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20240830","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jnnp.17.4.250","article-title":"The treatment of manic psychoses by the administration of lithium salts","volume":"17","author":"Schou","year":"1954","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-2-20240830","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","article-title":"Lithium salts in the treatment of psychotic excitement","volume":"2","author":"Cade","year":"1949","journal-title":"Med J Aust"},{"key":"R5-2-20240830","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2007-1017450","article-title":"The first era of lithium in medicine. An historical note","volume":"16","author":"Johnson","year":"1983","journal-title":"Pharmacopsychiatria"},{"key":"R6-2-20240830","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40345-019-0145-0","article-title":"Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy","volume":"7","author":"Jauhar","year":"2019","journal-title":"Int J Bipolar Disord"},{"key":"R7-2-20240830","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jad.2019.12.027","article-title":"Relationship between suicide mortality and lithium in drinking water: A systematic review and meta-analysis","volume":"264","author":"Barjasteh-Askari","year":"2020","journal-title":"J Affect Disord"},{"key":"R8-2-20240830","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40345-020-00215-z","article-title":"Overview of lithium's use: A nationwide survey","volume":"9","author":"P\u00e9rez de Mendiola","year":"2021","journal-title":"Int J Bipolar Disord"},{"key":"R9-2-20240830","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/cells10020255","article-title":"Lithium and therapeutic targeting of GSK-3","volume":"10","author":"Snitow","year":"2021","journal-title":"Cells"},{"key":"R10-2-20240830","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1017\/pan.2018.26","article-title":"No longer lost in translation: Evidence that google translate works for comparative bag-of-words text applications","volume":"26","author":"de Vries","year":"2018","journal-title":"Polit Anal"},{"key":"R13-2-20240830","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R15-2-20240830","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.410130232","article-title":"Action myoclonus in lithium toxicity","volume":"13","author":"Rosen","year":"1983","journal-title":"Ann Neurol"},{"key":"R16-2-20240830","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1176\/ajp.132.5.536","article-title":"Cogwheel rigidity related to lithium maintenance","volume":"132","author":"Shopsin","year":"1975","journal-title":"Am J Psychiatry"},{"key":"R17-2-20240830","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004850-199400920-00010","article-title":"Chronic lithium neurotoxicity presenting as Parkinson's disease","volume":"9","author":"Lecamwasam","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"key":"R18-2-20240830","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/ajp.142.3.364","article-title":"Iron pigment in the brain of a man with tardive dyskinesia","volume":"142","author":"Campbell","year":"1985","journal-title":"Am J Psychiatry"},{"key":"R19-2-20240830","first-page":"604","article-title":"Creutzfeldt-Jakob-like EEG changes in a case of fatal lithium toxicity","volume":"28","author":"I\u015fikay","year":"2011","journal-title":"J Neurol Sci"},{"key":"R21-2-20240830","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1176\/ajp.133.4.444","article-title":"Extrapyramidal side effects in lithium maintenance therapy","volume":"133","author":"Branchey","year":"1976","journal-title":"Am J Psychiatry"},{"key":"R22-2-20240830","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1176\/ajp.136.9.1225","article-title":"Cogwheel rigidity during chronic lithium therapy","volume":"136","author":"Asnis","year":"1979","journal-title":"Am J Psychiatry"},{"key":"R23-2-20240830","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1176\/ajp.137.8.941","article-title":"Age, dementia, dyskinesias, and lithium response","volume":"137","author":"Himmelhoch","year":"1980","journal-title":"Am J Psychiatry"},{"key":"R24-2-20240830","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ana.410120416","article-title":"Treatment of \u201con-off\u201d phenomena with lithium","volume":"12","author":"Lieberman","year":"1982","journal-title":"Ann Neurol"},{"key":"R25-2-20240830","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0165-0327(83)90010-1","article-title":"Parkinsonian symptoms with lithium, lithium-neuroleptic, and lithium-antidepressant treatment","volume":"5","author":"Per\u00e9nyi","year":"1983","journal-title":"J Affect Disord"},{"key":"R26-2-20240830","first-page":"87","article-title":"A study of side effects of lithium","volume":"25","author":"Rao","year":"1983","journal-title":"Indian J Psychiatry"},{"key":"R27-2-20240830","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/096032718700600410","article-title":"Self-poisoning and therapeutic intoxication with lithium","volume":"6","author":"Dyson","year":"1987","journal-title":"Hum Toxicol"},{"key":"R28-2-20240830","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0303-8467(87)80072-0","article-title":"Permanent neurological sequelae due to lithium toxicity","volume":"89","author":"Nagaraja","year":"1987","journal-title":"Clin Neurol Neurosurg"},{"key":"R29-2-20240830","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0149-7634(88)80052-6","article-title":"Differential responsiveness to lithium in patients with Tourette disorder","volume":"12","author":"Kerbeshian","year":"1988","journal-title":"Neurosci Biobehav Rev"},{"key":"R30-2-20240830","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1176\/ajp.145.11.1455","article-title":"Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia","volume":"145","author":"Nasrallah","year":"1988","journal-title":"Am J Psychiatry"},{"key":"R31-2-20240830","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S1461145703003870","article-title":"Safety and efficacy of combined clozapine-lithium pharmacotherapy","volume":"7","author":"Bender","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"R32-2-20240830","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12888-018-1622-1","article-title":"Reasons for lithium discontinuation in men and women with bipolar disorder: A retrospective cohort study","volume":"18","author":"\u00d6hlund","year":"2018","journal-title":"BMC Psychiatry"},{"key":"R33-2-20240830","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/1516-4446-2020-1007","article-title":"Where are lithium carbonate, typical antipsychotics, imipramine, and some other efficacious medications?","volume":"43","author":"Nardi","year":"2020","journal-title":"Braz J Psychiatry"},{"key":"R34-2-20240830","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jad.2018.10.094","article-title":"Lithium monotherapy-induced tardive dyskinesia","volume":"244","author":"Fountoulakis","year":"2019","journal-title":"J Affect Disord"},{"key":"R35-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02193747","article-title":"On the pathogenesis of abnormal involuntary movements in lithium-treated patients with major affective disorder","volume":"241","author":"Axelsson","year":"1991","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R36-2-20240830","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.155.1.55","article-title":"Tardive dyskinesia in bipolar affective disorder: Relationship to lithium therapy","volume":"155","author":"Dinan","year":"1989","journal-title":"Br J Psychiatry"},{"key":"R37-2-20240830","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40673-019-0100-y","article-title":"Tremor after long term lithium treatment; is it cortical myoclonus?","volume":"6","author":"Sarrigiannis","year":"2019","journal-title":"Cerebellum Ataxias"},{"key":"R38-2-20240830","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archneur.60.3.401","article-title":"Cortical myoclonus during lithium exposure","volume":"60","author":"Caviness","year":"2003","journal-title":"Arch Neurol"},{"key":"R39-2-20240830","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1073\/pnas.95.14.8363","article-title":"Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex","volume":"95","author":"Dixon","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-2-20240830","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/WNF.0000000000000388","article-title":"Dose-dependent effects of lithium treatment on the aggravation of antipsychotic-induced Pisa syndrome","volume":"43","author":"Hsieh","year":"2020","journal-title":"Clin Neuropharmacol"},{"key":"R41-2-20240830","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/sj.mp.4001018","article-title":"PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers","volume":"7","author":"Manji","year":"2002","journal-title":"Mol Psychiatry"},{"key":"R42-2-20240830","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/0269881113499204","article-title":"Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression","volume":"27","author":"Nugent","year":"2013","journal-title":"J Psychopharmacol"},{"key":"R43-2-20240830","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2018.04.037","article-title":"DAT-SPECT imaging in cases of drug-induced Parkinsonism in a specialty movement disorders practice","volume":"53","author":"Yomtoob","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"R44-2-20240830","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(73)91390-1","article-title":"Lithium and levodopa in Parkinsonism","volume":"1","author":"Dal\u00e9n","year":"1973","journal-title":"Lancet"},{"key":"R45-2-20240830","doi-asserted-by":"crossref","first-page":"140","DOI":"10.14712\/23362936.2021.14","article-title":"Valproate-associated movement disorder: A literature review","volume":"122","author":"Rissardo","year":"2021","journal-title":"Prague Med Rep"},{"key":"R46-2-20240830","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.mp.4000494","article-title":"Anti-bipolar therapy: Mechanism of action of lithium","volume":"4","author":"Jope","year":"1999","journal-title":"Mol Psychiatry"},{"key":"R47-2-20240830","first-page":"55","article-title":"An autopsy case of cerebellar degeneration following lithium intoxication with neuroleptic malignant syndrome","volume":"43","author":"Naramoto","year":"1993","journal-title":"Acta Pathol Jpn"},{"key":"R48-2-20240830","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/089198879500800208","article-title":"Disabling Parkinsonism due to lithium: A case report","volume":"8","author":"Holroyd","year":"1995","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R49-2-20240830","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.jagp.2016.01.088","article-title":"Lithium-induced Parkinsonism in a bipolar patient","volume":"24","author":"Glass","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"R50-2-20240830","first-page":"1075","article-title":"Lithium intoxication producing chorea athetosis with recovery","volume":"48","author":"Peters","year":"1949","journal-title":"Wis Med J"},{"key":"R51-2-20240830","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.kjms.2016.02.001","article-title":"Prolonged dyskinesia following lithium intoxication in an elderly patient with bipolar I disorder","volume":"32","author":"Huang","year":"2016","journal-title":"Kaohsiung J Med Sci"},{"key":"R52-2-20240830","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/AOMD.AOMD_35_19","article-title":"Bupropion-associated movement disorders: A systematic review","volume":"3","author":"Pitton Rissardo","year":"2020","journal-title":"Ann Mov Disord"},{"key":"R53-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41983-020-00197-w","article-title":"Cinnarizine-and flunarizine-associated movement disorder: A literature review","volume":"56","author":"Rissardo","year":"2020","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"R54-2-20240830","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R55-2-20240830","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neubiorev.2008.10.001","article-title":"Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: A review and synthesis","volume":"33","author":"Ng","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"R56-2-20240830","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-013-0039-0","article-title":"Potential mechanisms of action of lithium in bipolar disorder. Current understanding","volume":"27","author":"Malhi","year":"2013","journal-title":"CNS Drugs"},{"key":"R57-2-20240830","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/WNF.0000000000000395","article-title":"Topiramate-associated movement disorder: Case series and literature review","volume":"43","author":"Rissardo","year":"2020","journal-title":"Clin Neuropharmacol"},{"key":"R58-2-20240830","first-page":"144","article-title":"EEG-changes during lithium therapy","volume":"42","author":"Helmchen","year":"1971","journal-title":"Nervenarzt"},{"key":"R59-2-20240830","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/WNF.0000000000000453","article-title":"Lithium-induced treatment-resistant akathisia: A case report and literature overview","volume":"44","author":"Demir","year":"2021","journal-title":"Clin Neuropharmacol"},{"key":"R60-2-20240830","first-page":"285","article-title":"Non-tardive orofacial akathisia with dental sensory phenomenon: 719","volume":"30","author":"Scorr","year":"2015","journal-title":"Mov Disord"},{"key":"R61-2-20240830","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/tcmj.tcmj_13_20","article-title":"Mirtazapine-associated movement disorders: A literature review","volume":"32","author":"Rissardo","year":"2020","journal-title":"Tzu Chi Med J"},{"key":"R62-2-20240830","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/cap.2012.2253","article-title":"Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit\/hyperactivity disorder and mood symptoms","volume":"22","author":"Potter","year":"2012","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R63-2-20240830","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/WNF.0000000000000387","article-title":"Carbamazepine-, oxcarbazepine-, eslicarbazepine-associated movement disorder: A literature review","volume":"43","author":"Rissardo","year":"2020","journal-title":"Clin Neuropharmacol"},{"key":"R64-2-20240830","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp.50.2.235","article-title":"Cerebellar syndrome in lithium poisoning: A case of partial recovery","volume":"50","author":"Tesio","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Brain Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_77_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:02:55Z","timestamp":1787756575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_77_21"}},"subtitle":["A literature review"],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/bc.bc_77_21","relation":{},"ISSN":["2394-8108"],"issn-type":[{"value":"2394-8108","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}